We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-5.4%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$496M
AUM Growth
-$67M
(-12%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-2.49%
Top 10 Holdings %
Top 10 Hldgs %
25.38%
Holding
128
New
22
Increased
39
Reduced
44
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icon
ICLR
|
+$7.57M |
| 2 |
iRhythm Holdings
IRTC
|
+$6.12M |
| 3 |
Travere Therapeutics
TVTX
|
+$5.83M |
| 4 |
Lantheus
LNTH
|
+$5.59M |
| 5 |
Alkermes
ALKS
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$12.4M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$8.48M |
| 3 |
Health Catalyst
HCAT
|
+$6.58M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$5.99M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$5.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.62% |
| 2 | Industrials | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$387B
| $18.5M | 3.72% |
35,925
+3,225
| +10% | +$1.62M |
|
2
HealthEquity
HQY
$8.17B
| $14.8M | 2.98% |
240,600
+600
| +0.3% | +$38.4K |
|
|
RCM
3
DELISTED
R1 RCM Inc. Common Stock
RCM
| $12.7M | 2.55% |
603,994
+75,500
| +14% | +$1.71M |
|
|
NARI
4
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $12.5M | 2.52% |
183,760
+22,700
| +14% | +$1.63M |
|
5
Johnson & Johnson
JNJ
$609B
| $12M | 2.43% |
67,850
-4,900
| -7% | -$873K |
|
6
BioMarin Pharmaceuticals
BMRN
$11.5B
| $11.7M | 2.37% |
141,730
+36,600
| +35% | +$2.91M |
|
7
Evolent Health
EVH
$654M
| $11.4M | 2.3% |
372,142
-20,000
| -5% | -$583K |
|
8
Arvinas
ARVN
$517M
| $11.2M | 2.26% |
266,992
+100,861
| +61% | +$5.06M |
|
|
SYNH
9
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $10.9M | 2.21% |
152,706
-23,600
| -13% | -$1.73M |
|
10
Insmed
INSM
$23.5B
| $10.2M | 2.05% |
515,542
-12,800
| -2% | -$268K |
|
11
PTC Therapeutics
PTCT
$6.52B
| $9.61M | 1.94% |
239,908
-24,483
| -9% | -$858K |
|
12
Inspire Medical Systems
INSP
$1.46B
| $9.44M | 1.9% |
51,650
| – | – |
|
13
AtriCure
ATRC
$1.77B
| $9.34M | 1.88% |
228,532
+10,368
| +5% | +$491K |
|
|
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $9.2M | 1.85% |
63,150
-42,700
| -40% | -$5.45M |
|
|
AGTI
15
DELISTED
Agiliti Inc
AGTI
| $9.09M | 1.83% |
443,247
-36,400
| -8% | -$726K |
|
16
Privia Health
PRVA
$3.39B
| $8.65M | 1.74% |
297,200
-64,350
| -18% | -$1.64M |
|
|
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.25M | 1.66% |
226,764
+17,764
| +8% | +$645K |
|
|
18
iRhythm Holdings
IRTC
$3.64B
| $8.1M | 1.63% |
75,000
+46,200
| +160% | +$6.12M |
|
19
Exelixis
EXEL
$14.1B
| $7.97M | 1.61% |
383,025
+19,185
| +5% | +$395K |
|
20
Arcus Biosciences
RCUS
$3.44B
| $7.9M | 1.59% |
311,782
-26,698
| -8% | -$654K |
|
|
21
Icon
ICLR
$13.1B
| $7.79M | 1.57% |
35,940
+33,740
| +1,534% | +$7.57M |
|
|
APLS
22
DELISTED
Apellis Pharmaceuticals
APLS
| $6.93M | 1.4% |
153,250
+83,750
| +121% | +$3.82M |
|
23
Pfizer
PFE
$143B
| $6.78M | 1.37% |
129,400
-55,500
| -30% | -$2.83M |
|
|
TPTX
24
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.77M | 1.36% |
90,000
-190,850
| -68% | -$8.48M |
|
|
AXNX
25
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.72M | 1.35% |
118,650
+69,150
| +140% | +$3.79M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Sectoral Asset Management held 128 positions worth $496M, down 12% from $563M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management's Q2 2022 filing shows 22 new, 39 increased, 44 reduced and 16 closed positions. Its largest new stake was Travere Therapeutics: 232,000 shares worth $5.62M. The largest sale was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $12.4M.
By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Industrials.
- Sectoral Asset Management's largest Q2 2022 buy was Travere Therapeutics: 232,000 shares worth $5.62M.
- Sectoral Asset Management added most to Icon in Q2 2022, an estimated $7.57M increase.
- Sectoral Asset Management's biggest Q2 2022 reduction was Turning Point Therapeutics, Inc. Common Stock, cutting an estimated $8.48M.
- Sectoral Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $12.4M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $496M portfolio in Q2 2022.
- Sectoral Asset Management opened 22 new positions and closed 16 in Q2 2022.
- Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $496M.
Based on Sectoral Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.